Gaiamer Biotechnologies, Inc. — Form D/A
Gaiamer Biotechnologies, Inc. of Inglewood, CA, a company, filed a Form D amendment with the SEC on 2021-07-16. The offering totals $5.0M, of which $100K was reported sold. Industry: Manufacturing.
Offering
- Filed: 2021-07-16
- Form: D/A
- Accession: 0001817875-21-000001
- Industry: Manufacturing
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $100K
- Remaining: $4.9M
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2020-06-24
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-371022
Issuer
- Name: Gaiamer Biotechnologies, Inc.
- CIK: 0001817875
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 420 Hindry Ave. Unit A, Inglewood, CA, 90301
- Phone: 3239650063
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Charles Caliman | Director | Los Angeles, CA |
| Jihene Dhaouadi | Director | Long Beach, CA |
| Araya Mesfin | Director | Atlanta, GA |
| Christopher Sargent | Director | San Francisco, CA |
| Jerry Schindler | Director | Acworth, GA |
| Keith Tinsley | Director | Bellflower, CA |
| Thomas Trimbach | Director | Los Angeles, CA |
| Charles Caliman | Executive Officer | Los Angeles, CA |
| Christopher Sargent | Executive Officer | San Francisco, CA |
| Keith Tinsley | Executive Officer | Bellflower, CA |
| Thomas Trimbach | Executive Officer | Los Angeles, CA |
Other filings by this issuer (1)
More